ArticleGland surgery2025
Preoperative anti-thyroid antibodies predict malignancy risk in cytologically indeterminate thyroid nodules: a prospective multicenter study.
Article in Gland surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between autoimmune thyroiditis and clinicopathological features of papillary thyroid carcinoma: a prospective study.Archives of endocrinology and metabolism · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cytologically indeterminate thyroid nodules (CITNs) are heterogeneous, and their assessment remains controversial. In this study, we examined the prognostic utility of anti-thyroid antibodies for predicting thyroid cancer (TC) in CITNs. Methods: This prospective multicenter analysis included all patients with CITNs who were surgically treated between August 2023 and August 2024 at two hospitals in Saudi Arabia; preoperative anti-thyroid antibodies [thyroid peroxidase and thyroglobulin antibodies (TgAbs)], thyroid stimulating hormone (TSH), and a definitive histological diagnosis were required for inclusion. Multivariate analysis was used to identify independent predictors of TC. Results: This study included 76 individuals; 70/76 (92.1%) were women. Overall, 43/76 (56.6%) nodules had a cytological diagnosis of atypia of undetermined significance (AUS) (Bethesda III), whereas 33/76 (43.4%) were follicular neoplasms (FNs) (Bethesda IV). Pathological analysis revealed that 56/76 (73.7%) patients had benign nodules and 20/76 (26.3%) had malignant tumors. The coexistence of elevated levels of both antibodies and TSH demonstrated the highest odds ratio [3.10; 95% confidence interval (CI): 1.14-5.47], signifying a significant correlation with TC (P=0.003). Furthermore, high levels of one antibody along with elevated TSH levels resulted in an odds ratio of 2.25 (95% CI: 1.02-6.44), indicating a significant association with TC (P=0.04). The multivariate analysis identified Bethesda IV cytological diagnoses, the presence of Hashimoto's thyroiditis, and TSH levels >1 mIU/L as independent predictors of TC. Conclusions: Elevated anti-thyroid antibody and TSH levels were effective predictors of TC in CITNs. These findings may help guide endocrine surgeons managing patients with these nodules.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.